Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin

BACKGROUND: COVID-19 has been associated with a high prevalence of myocardial injury and increased cardiovascular morbidity. Copeptin, a marker of vasopressin release, has been previously established as a risk marker in both infectious and cardiovascular disease. METHODS: This prospective, observati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Christoph C., Ahmed, Amro, Kassem, Mona, Freynhofer, Matthias K., Jäger, Bernhard, Aicher, Gabriele, Equiluz-Bruck, Susanne, Spiel, Alexander O., Vafai-Tabrizi, Florian, Gschwantler, Michael, Fasching, Peter, Wojta, Johann, Giannitsis, Evangelos, Huber, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592075/
https://www.ncbi.nlm.nih.gov/pubmed/34782921
http://dx.doi.org/10.1007/s00392-021-01970-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592075/
https://www.ncbi.nlm.nih.gov/pubmed/34782921
http://dx.doi.org/10.1007/s00392-021-01970-4

Ejemplares similares